Purpose: Proton vertebral body sparing craniospinal irradiation (VBS CSI) treats the thecal sac while avoiding the anterior vertebral bodies in effort to reduce myelosuppression and growth inhibition. However, robust treatment planning needs to compensate proton range uncertainty, contributing unwanted doses within the vertebral bodies. This work aims to develop an early in vivo radiation damage quantification method using longitudinal magnetic resonance (MR) scans to quantify dose effect during fractionated CSI. Materials and methods: Ten pediatric patients were enrolled in a prospective clinical trial of proton VBS CSI receiving 23.4-36 Gy. Monte Carlo robust planning was used with spinal clinical target volumes defined as the thecal sac and neural foramina. T1/T2-weighted MR scans were acquired before, during, and after treatments to detect transition from hematopoietic to less metabolically active fatty marrow. MR signal intensity histograms at each time point were analyzed and fitted by multi-Gaussian models to quantify radiation damages. Results: Fatty marrow filtration was observed on MR images as early as the fifth fraction of treatment. Maximum radiation-induced marrow damage occurred 40-50 days from the treatment start, followed by marrow regeneration. The mean damage ratios were 0.23, 0.41, 0.59, and 0.54 corresponding to 10, 20, 40, and 60 days from the treatment start. Conclusions: We demonstrated a non-invasive method to identify early vertebral marrow damage based on radiation-induced fatty marrow replacement. The proposed method can be potentially used to quantify the quality of CSI vertebral sparing to preserve metabolically active hematopoietic bone marrow.
